Prosecution Insights
Last updated: August 14, 2026

The University of Toledo

24 pending office actions • 18 art units • 23 examiners • 0 of 24 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Portfolio Summary

24
Total Pending OAs
18
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (46%)
11
Medium (46%)
2
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (8%)
§103 only11 (46%)
§112 only1 (4%)
Double-patenting only1 (4%)
Multi-statute (no §101)9 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
21% of docket
4
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUYNH, PHUONG N 2 65.7% +53.6%
MILO, MICHAEL 1 50.0% +54.9%
TRINH, THANH TRUC 1 22.0% +11.3%
BURKE, MATTHEW RYAN 1
HOWELL, GWYNNETH LINNEA 1 42.0% +80.7%
SPIES, BRADLEY R 1 74.1% +20.7%
MCEVOY, THOMAS M 1 70.8% +35.5%
MALEVIC, DJURA 1 78.1% +10.5%
MACH, ANDRE 1 45.9% +53.2%
DANG, ANH TIEU 1 65.4% +35.8%

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18274549 C PRIME AGENTS FOR TREATING METABOLIC DISORDERS BRAUN, MADELINE E 12d
18353183 Synergistic Inhibition of eIF5A and Notch Signaling HUYNH, PHUONG N 28d
18205012 Advanced Driving Assistance System Using Fuzzy Logic ABD EL LATIF, HOSSAM M 86d
18768377 Materials and Methods to Improve the Stability of Metal Halide Perovskites TRINH, THANH TRUC
18674217 Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs HUYNH, PHUONG N
18606189 Automatic Fraction Collector SPIES, BRADLEY R
18688151 SIZE ADJUSTABLE AORTIC ENDOGRAFT FENESTRATION DEVICE AND RETRIEVABLE VESSEL MARKER MCEVOY, THOMAS M
18410384 AORTIC PUNCH DANG, ANH TIEU

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18951851 Modular Hip Distractor MILO, MICHAEL 16d overdue
18353183 Synergistic Inhibition of eIF5A and Notch Signaling HUYNH, PHUONG N 28d
18417805 COMPOUNDS HAVING SELECTIVE INACTIVATION ACTIVITY MACH, ANDRE 70d
18768377 Materials and Methods to Improve the Stability of Metal Halide Perovskites TRINH, THANH TRUC
18674217 Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs HUYNH, PHUONG N
18640844 PRESSURE ULCER BOOT HOWELL, GWYNNETH LINNEA
18606189 Automatic Fraction Collector SPIES, BRADLEY R
18688151 SIZE ADJUSTABLE AORTIC ENDOGRAFT FENESTRATION DEVICE AND RETRIEVABLE VESSEL MARKER MCEVOY, THOMAS M

Top Art Units

Art UnitApps
1641 2
1795 2
3786 1
1726 1
1619 1
1645 1
3774 1
1615 1
3771 1
1674 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18951851 Modular Hip Distractor MILO, MICHAEL 3786 §103 Final Rejection 16d overdue Pending Nov 19, 2024
18768377 Materials and Methods to Improve the Stability of Metal Halide Perovskites TRINH, THANH TRUC 1726 §103§112 Non-Final OA Pending Jul 10, 2024
18746938 FLUSHABLE WET WIPES BURKE, MATTHEW RYAN 1619 §103 Non-Final OA Pending Jun 18, 2024
18674217 Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs HUYNH, PHUONG N 1641 §101§103§112DP Non-Final OA Pending May 24, 2024
18640844 PRESSURE ULCER BOOT HOWELL, GWYNNETH LINNEA §103 Non-Final OA Pending Apr 19, 2024
18606189 Automatic Fraction Collector SPIES, BRADLEY R 1645 §103§112 Non-Final OA Pending Mar 15, 2024
18688151 SIZE ADJUSTABLE AORTIC ENDOGRAFT FENESTRATION DEVICE AND RETRIEVABLE VESSEL MARKER MCEVOY, THOMAS M 3774 §102§103 Non-Final OA Pending Feb 29, 2024
18580987 SOLID PHANTOM DEVICE FOR BEAM SCANNING MALEVIC, DJURA §103 Non-Final OA Pending Jan 19, 2024
18417805 COMPOUNDS HAVING SELECTIVE INACTIVATION ACTIVITY MACH, ANDRE 1615 §103 Final Rejection 70d Pending Jan 19, 2024
18410384 AORTIC PUNCH DANG, ANH TIEU 3771 §103§112 Non-Final OA Pending Jan 11, 2024
18410121 ELISA Assay for Measuring Function of Properdin and Kits for Conducting ELISA Assays using Anti-properdin Antibodies MARCSISIN, ELLEN JEAN DP Non-Final OA Pending Jan 11, 2024
18506571 MONOCLONAL IGM ANTIBODIES FROM ENTIRELY CARBOHYDRATE CONSTRUCTS LI, RUIXIANG 1674 §102§112 Non-Final OA Pending Nov 10, 2023
18370111 SENSOR FOR THE DETECTION OF HYDROXYL FREE RADICALS QIAN, SHIZHI 1795 §102§103 Non-Final OA Pending Sep 19, 2023
18238687 Ferroptosis-HDAC Inhibitor Hybrid Anticancer Agents SEITZ, ANTHONY JOSEPH 1629 §112 Final Rejection 25d overdue Pending Aug 28, 2023
18274549 C PRIME AGENTS FOR TREATING METABOLIC DISORDERS BRAUN, MADELINE E 1624 §103§112 Non-Final OA 12d Pending Jul 27, 2023
18353183 Synergistic Inhibition of eIF5A and Notch Signaling HUYNH, PHUONG N 1641 §103§112Other Final Rejection 28d Pending Jul 17, 2023
18205012 Advanced Driving Assistance System Using Fuzzy Logic ABD EL LATIF, HOSSAM M 3664 §101§103 Final Rejection 86d Pending Jun 02, 2023
18093057 ANTIMICROBIAL FILTRATION HORGER, KIM S. 1784 §103 Final Rejection 46d overdue Pending Jan 04, 2023
17859260 THREE-WAY UROLOGY CATHETER STOPCOCK AND UROLOGY CATHETER STOPCOCK ASSEMBLY PATEL, SHEFALI DILIP 3783 §103 Non-Final OA 54d Pending Jul 07, 2022
17790288 STRATIFYING RISK OF MALIGNANCY IN INDETERMINATE THYROID NODULES AND IMMUNO-GENOMIC MARKERS FOR EARLY DETECTION OF THYROID CANCER MACFARLANE, STACEY NEE 1675 §103 Non-Final OA 15d overdue Pending Jun 30, 2022
17775932 Methods and Kits using Internal Standards to Control for Complexity of Next Generation Sequencing(NGS) Libraries VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103 Non-Final OA 36d overdue Pending May 11, 2022
17737325 Emulsion Formation Assisted by Corona Discharge and Electrohydrodynamic Pumping BRAZIN, JACQUELINE 1798 §103 Non-Final OA 27d Pending May 05, 2022
17178455 SUPER SENSITIVE SENSOR FOR THE DETECTION OF HYDROXYL FREE RADICALS WITH SCAVENGING PROPERTIES SUN, CAITLYN MINGYUN 1795 §103 Non-Final OA 1d overdue Pending Feb 18, 2021
18789242 COMPOSITION COMPRISING BETA LACTAM FOR TREATING ALCOHOL DEPENDENCE AND ALCOHOL ASSOCIATED DISEASES OR CONDITIONS ROBINSON, MIKHAIL O'DONNEL §102§103 Non-Final OA Pending Jul 30, 2024

Managing The University of Toledo's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month